MUC16 and metastatic malignant neoplasm in the lymph nodes: These factors included age, diabetes mellitus, FIGO stage, pathological grade, lymph node metastasis, radiotherapy, chemotherapy, FIB, serum CA125, and postoperative serum CA125, all of which had p-values less than 0.05.